Avadel Pharmaceuticals PLC (NASDAQ:AVDL)
| 5.20 Delayed Data As of 3:59pm ET |  +0.19 / +3.79%Today’s Change | 3.46 Today|||52-Week Range 13.49 | -31.13% Year-to-Date |
Latest AVDL News | Press Releases
No recent news for Avadel Pharmaceuticals PLC.
Today’s Trading
| Previous close | 5.01 |
| Today’s open | 5.48 |
| Day’s range | 5.01 - 5.23 |
| Volume | 9,073 |
| Average volume (3 months) | 759,304 |
| Market cap | $316.1M |
Data as of 3:59pm ET, 10/22/2020
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +91.65% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -42.61% |
| P/E ratio | 19.2 |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRNAVerona Pharma PLC | +0.25 | +4.51% |
| EIGREiger BioPharmaceuti... | +0.23 | +2.35% |
| AFMDAffimed NV | +0.04 | +1.38% |
| CTMXCytomX Therapeutics ... | +0.18 | +2.74% |
Data as of 3:59pm ET, 10/22/2020
Financials
| Next reporting date | November 10, 2020 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $59.2M |
| Annual profit (last year) | -$33.2M |
| Net profit margin | -56.11% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
